Company news

Bio-Gene Technology Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Investor Webinar - FY24 Half Year Review

March 4, 2024

Appendix 4D - Half Year Accounts - 31 December 2023

February 25, 2024

Appendix 4C - 31 December 2023

January 28, 2024

Bio-Gene Receives R&D Tax Incentive

January 18, 2024

Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan

December 12, 2023

BGT Corporate Presentation

December 12, 2023

BGT 2023AGM - CEO's Presentation

November 23, 2023

BGT 2023AGM - CEO's Address

November 23, 2023

BGT 2023AGM - Chairman's Address

November 23, 2023

Result of Share Purchase Plan Offer (SPP)

October 3, 2023

Launch of SPP & Further Funds Raised under Placement

September 11, 2023

Capital Raise & Presentation

September 1, 2023

BGT Update Company Presentation

August 11, 2023

New USA Patent for the Insecticide Market

August 1, 2023

Appendix 4E and 2023 Annual Report

July 31, 2023

BGT Appoints New CEO

July 28, 2023

BGT Executes Agreement with STK

July 26, 2023

BGT selected for USA CDC Funded Program

July 23, 2023

Allowance of USA Patent

June 28, 2023

GRDC Confirms Support for Flavocide in Grain Storage

May 11, 2023

Bio-Gene Update Company Presentation

May 3, 2023

Appendix 4C - 31 March 2023

April 26, 2023

Synergy Studies Offer Significant Commercial Opportunities

April 25, 2023

Board and Management Changes

April 23, 2023

Bio-Gene Extends Commercial Development Agreement

April 12, 2023

Allowance of United States Patent

March 16, 2023

Bio-Gene Company Update Presentation

February 22, 2023

Appendix 4D - Half Year Accounts - 31 December 2022

February 22, 2023

Appendix 4C - 31 December 2022

January 30, 2023

Bio-Gene and STK Agree Binding Terms on Global Collaboration

January 19, 2023

Bio-Gene Submits Application for Plant Breeders Rights

November 30, 2022

Appendix 4C - 30 September 2022

October 26, 2022

Significant Developments in Molecule Manufacturing - Update

October 25, 2022

Appendix 4E and 2022 Annual Report

August 16, 2022

Appendix 4C - 30 June 2022

July 28, 2022

Update on Development Program with BASF

May 11, 2022

Appendix 4C - 31 March 2022

April 26, 2022

Bio-Gene Executes Commercial Development Agreement

April 3, 2022

Strategic Placement of $1.5 million to Cornerstone Investor

March 14, 2022

Positive Stored Grain Pest Results

March 6, 2022

Grant of United States Patent

March 1, 2022

Appendix 4D - Half Year Accounts - 31 December 2021

February 16, 2022

Appendix 4C - 31 December 2021

January 30, 2022

Bio-Gene Completes Capital Raising of $3.2 Million

December 8, 2021

Bio-Gene to Progress Synergy Research

December 5, 2021

Bio-Gene 2021 AGM - Chairmans Address

November 30, 2021

Bio-Gene 2021 AGM - CEOs Presentation

November 30, 2021

Bio-Gene 2021 AGM Presentation

November 30, 2021

Appendix 4C - 30 September 2021

October 27, 2021

Bio-Gene Executes Option Agreement with Clarke

October 26, 2021

← Newer news releases · Older news releases →

Decks

The 5 newest of 37 decks. Every deck is listed under its year.